Real-world data show reduction in use of urate-lowering therapy among people with type 2 diabetes using SGLT2 inhibitors.

Gout Gout has been compared to an Australian track legend as his meteoric rise continues. The teenage sensation has already ...

The 16-year-old Gout has had the wildest year of his young life as he’s been compared to 100m and 200m world record holder ...

He has been the voice for a staggering 12 Summer Olympic Games, now Australia's undisputed king of sports calling is taking ...

Healthcare products provider RHEA Generics is committed to promoting affordable healthcare by offering generic medications ...

Efforts to combat hyperuricemia may find help from gut microbes, according to Dylan Dodd, MD, PhD, who spoke at the annual ...

Protalix BioTherapeutics, Inc. (NYSE: PLX), a biopharmaceutical company specializing in the development, production, and commercialization of recombinant therapeutic proteins, recently disclosed its ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

In a shocking turn of events, Spirit Airlines is reportedly preparing to file for Chapter 11 bankruptcy protection. This news ...

Gout causes sudden flares of joint pain, which often arise during the nighttime, and in the big toe, though it may affect other joints including the ankles | Genetics And Genomics ...

Excess sugar links to many health risks. Learn how to cut back and replenish energy levels, prevent chronic diseases, and improve overall health.

The use of SGLT2 inhibitors vs sulfonylurea was associated with a reduced risk for incident gout and MACE among patients with type 2 diabetes with/at risk for gout.